Cogent Biosciences stock hits 52-week high at $17.10
PositiveFinancial Markets

Cogent Biosciences has reached a significant milestone as its stock price hit a 52-week high of $17.10. This achievement reflects growing investor confidence and positive market sentiment towards the company's future prospects. As Cogent continues to innovate and expand its offerings, this surge in stock value is a promising sign for both current and potential investors.
— Curated by the World Pulse Now AI Editorial System